• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Antibodies against apoptotic cells may predict kidney transplant rejection

bySarah StapletonandChaz Carrier
June 19, 2014
in Chronic Disease, Nephrology, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Kidney transplant patients have higher IgG reactivity to apoptotic cells (IRAC) than healthy patients. 

2. Greater levels of pretransplant IRAC were associated with increased risk of allograft rejection, and were particularly predictive of antibody-mediated rejection (AMR). 

Evidence Rating Level: 2 (Good)            

Study Rundown: While immunosuppressive therapies have greatly reduced acute cellular rejection of kidney transplants, they have not succeeded in preventing the long-term kidney failure associated with other modes of rejection. In determining candidates for kidney transplant, patient serum is often screened for predictive markers of transplant failure or success. While many studies have shown correlation between HLA-specific antibodies and poor transplant outcome, the contribution of non-HLA antibodies remains less clear. This study evaluates correlation between pretransplant IgG antibody reactivity to apoptotic cells(IRAC) and long-term kidney transplant success. When compared to healthy control subjects, kidney transplant patients were found to have higher pre-operative IRAC levels. In patient comparisons, higher IRAC predicted graft failure. Interestingly, the predictive value of IRAC for poor graft survival was only significant in long-term (> 12months) evaluations. Supporting the likelihood that IRAC plays an active role in this transplant rejection, patients with antibody-mediated rejection(AMR) had higher IRAC levels than patients with other mediators of graft loss. Particularly, IgG1 and IgG3, known to activate the complement pathway associated with graft failure, were found to bind apoptotic cells. This study was limited by its retrospective nature, one consequence of which was lack of post-transplant patient serum samples.

Click to read the study in American Journal of Transplantation

Relevant Reading: Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies

In-Depth [retrospective cohort]: This study examined pretransplant serum samples of 300 kidney transplant patients for IRAC as a predictive marker of transplant rejection. With a mean follow-up time of approximately 80 months, 46 of the 300 transplant patients experienced eventual transplant rejection. Thirty-seven percent of these graft rejections were a result of AMR. IgG antibodies purified from pretransplant patients and healthy specimen (n = 20) serum samples were evaluated for their reactivity to apoptotic Jurkat cells by flow cytometry. Mann-Whitney tests were used to compare reactivity of IgG between patient subgroups and between patients and healthy subjects. The Kaplan-Meier method was used to estimate survival events and comparisons were made using the log-rank test. Cox multivariate analysis accounted for confounding factors including reactivity to HLA antibodies, age, and race.

RELATED REPORTS

#VisualAbstract: Perioperative dexmedetomidine decreases the incidence of select complications following kidney transplantation

Perioperative dexmedetomidine decreases the incidence of select complications following kidney transplantation

#VisualAbstract Half of the organ transplant recipients who develop skin cancers post-transplant will develop at least another skin cancer within two years

This study found that IRAC was significantly higher in kidney transplant candidates than in healthy subjects (p = 0.011) and was predictive of poor graft survival in transplant patients (hazard ratio = 2.271; p <0.001). Of the 46 failed graft patients, the 17 that experienced antibody-mediated rejection had significantly higher IRAC levels (p = 0.033). Particular subsets IgG1 and IgG3 were found to be most reactive to apoptotic cells.

More from this author: Modulating lymphocyte populations decreases graft rejection in mice,Adding Evolocumab to statin therapy further decreases LDL-C levels,Genetic variant linked to poor patient survival following lung transplantation, Genetic variations may predict outcomes for colorectal cancer patients, Neuroendocrine tumor marker pancreastatin may be predictive of survival 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: kidney transplant
Previous Post

Mental health patients at greater risk of becoming victims of homicide

Next Post

Meniscal allograft transplantation may improve knee function

RelatedReports

#VisualAbstract: Perioperative dexmedetomidine decreases the incidence of select complications following kidney transplantation
StudyGraphics

#VisualAbstract: Perioperative dexmedetomidine decreases the incidence of select complications following kidney transplantation

June 15, 2022
Patient Basics: Kidney Transplant
Chronic Disease

Perioperative dexmedetomidine decreases the incidence of select complications following kidney transplantation

June 9, 2022
#VisualAbstract Half of the organ transplant recipients who develop skin cancers post-transplant will develop at least another skin cancer within two years
StudyGraphics

#VisualAbstract Half of the organ transplant recipients who develop skin cancers post-transplant will develop at least another skin cancer within two years

October 29, 2021
Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact
Chronic Disease

Postponing renal replacement therapy may result in poor clinical outcomes in patients with severe acute kidney injury 

June 25, 2021
Next Post
Meniscal allograft transplantation may improve knee function

Meniscal allograft transplantation may improve knee function

Key predictors of recurrence and survival for Merkel Cell Carcinoma elucidated

Rising incidence of merkel cell carcinoma reported in Queensland, Australia

Infrared thermography reliably measures growth of infantile hemangiomas

Infrared thermography reliably measures growth of infantile hemangiomas

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Intravenous fluid restriction does not improve septic shock outcomes
  • Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients
  • Magnetic resonance based preoperative evaluation for perianal fistulas superior to traditional clinical method and improve surgical outcomes [Classics Series]
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.